April K. Salama MD

April K. Salama, MD, is Associate Professor at Duke University School of Medicine and Director of the Melanoma disease group at Duke Cancer Institute.

Dr. Salama earned her medical degree from the University of North Carolina School of Medicine. She completed her training with an internal medicine residency and hematology/oncology fellowship at The University of Chicago.

Dr. Salama has an interest in developing novel therapeutics for patients with advanced melanoma. Dr. Salama has developed a number of investigator-initiated clinical protocols with a focus on multi-modality care. She also serves as the national co-principal investigator of the dabrafenib/trametinib arm (EAY-131H) of the NCI-MATCH trial.

Dr. Salama is a member of numerous professional organizations and has authored or co-authored several scientific journal articles, book chapters, and abstracts. She is the past-recipient of the ASCO Cancer Foundation Merit Award and was a recipient of a 2017 NCI Cancer Clinical Investigator Team Leadership Award.

Dr. Salama is a member of the NCCN Melanoma Guidelines Panel.